Tel:   +44 (0)1608 641495

 

Page created with Lectora © 2008 Trivantis and Bovill de Maillet Limited

Bovill de Maillet Ltd trading as BdM Development, Station Road, Chipping Norton, Oxfordshire, OX7 5HX, Registered in England number 2671636 Vat Reg GB 596 3516 05

Welcome to our site for Lectora

 

BdM Development is one of the longest-standing UK and European resellers of Lectora from Trivantis Corporation. What ever you need to know about Lectora can be found here on this site.

 

Lectora has an extremely low learning curve and an abundance of practical and helpful features and functionality.   Lectora is the fastest, easiest-to-use, most comprehensive and cost-effective authoring and publishing software available. No other authoring software can provide such:

 

         Ease of use

         Speed of development

         Comprehensive authoring and publishing

         Extensibility

         Support for e-learning standards

 

With Lectora anyone with a basic knowledge of PCs can now create powerful, effective and engaging, media-rich content for the Internet, Intranets or CD-ROMs, without a line of programming code. Click here to discover why Lectora is widely recognised as the leader in rapid e- learning content development.

 

Add to that the range of services that BdM Development can provide to support both Lectora or your entire e-learning programme, and you need look no further.

Introducing

Lectora 2008

Announcing the release of Lectora 2008. In collaboration with Lectora users, the developers have added over 50 new features making it faster and more powerful than ever. Click here to learn more.

 

Essencia

Got Lectora content and want to launch and track it?

Essencia e-LMS

 

Spice up your Lectora presentations with engaging interactions and animations.

Raptivity

Here in the UK we wanted something that was easy to use, intuitive and easy to learn. With Lectora it is easy to create something basic while still learning, but it also has capabilities of producing something of very high quality if you have the knowledge.   

Andrew Young, Boehringer Ingelheim